News | August 02, 2022
Cadila launches generic sitagliptin versions to treat uncontrolled type 2 diabetes
The two generic drugs have been launched under the brand names Jankey & Sitenali.
The two generic drugs have been launched under the brand names Jankey & Sitenali.
The funds raised in the seed round will be used for research and development of Shri Chyawan Ayurved Product
Mittal will be driving expansion of the provider network across India
Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.
The introduction of Enverse is part of StimLabs' aim to simplify patient care for both physicians and the hospital systems
This facility will produce higher efficacy products that enjoy greater acceptance and enhanced profit marginsg
With $120m jointly invested in the newly-formed initiative, and with other strategic investors expected to join, the venture will develop an alternative, plant-based ingredient using biotechnology
EPR-Technologies is pursuing development of an unprecedented standard of emergency care when CPR fails
This new formulation represents a significant improvement over protease inhibitor-containing paediatric ARV formulations that have been used in South Africa for decades.
Gilman will be responsible for all business development and portfolio strategy efforts globally.
Subscribe To Our Newsletter & Stay Updated
